Deposition and cross-linking of newly synthesized type IV procollagen in lung matrix

Precision-cut tissue slices: applications in pharmacology and toxicology

Almost a decade has passed since the first paper describing the isolation and maintenance of precision-cut liver slices produced using a mechanical tissue slicer was published (1). Although tissue slices of various organs have been employed as an in vitro system for several decades, the lack of reproducibility within the slices and the relatively limited viability of the tissue preparations has prevented a widespread acceptance of the technique. The production of an automated slicer, capable of reproducibly producing relatively thin slices of tissue, as well as the development of a dynamic organ culture system, overcame several of these obstacles. Since that time, significant advances in the methods to produce and culture tissue slices have been made, as well as the application of the technique to several other organs, including kidney, lung and heart. This review will i) summarize the historical use of tissue slices prior to the development of the precision-cut tissue slice system; ii) briefly analyze current methods to produce precision-cut liver, kidney, lung and heart slices; and iii) discuss the applications of this powerful in vitro system to the disciplines of pharmacology and toxicology.

Interstitial lung disease in children

Interstitial lung disease in children is a heterogeneous group of disorders of both known and unknown causes that share a common histologic characteristic (i.e., inflammation of the pulmonary interstitium that may resolve completely, partially, or progress to derangement of alveolar structures with varying degrees of fibrosis). The inflammatory process, evoked as a result of injury to alveolar epithelium and/or the endothelium, is responsible for alveolar wall thickening that is the histologic marker of ILD. This article extrapolates some of the known pathogenic mechanisms of ILD from adult and animal models and applies this information for a better understanding of the pathogenesis of ILD in children. The clinical manifestations vary and are often subtle and nonspecific. There is no consensus on specific criteria for the clinical diagnosis of ILD in children. There are no pathognomonic laboratory criteria for the diagnosis of ILD in children other than the characteristic findings on histologic examination of the lung. It is important to make the diagnosis early to minimize lung damage. Therapy is directed toward the reduction of the inflammatory response to minimize or prevent the progression to fibrosis. ILD suffers from lack of uniform guidelines for diagnostic evaluation, therapy, and prognostic indicators essential for critical monitoring of disease activity. No one medical center has enough cases of ILD in children to allow objective evaluation of a significant number of cases with adequate longitudinal follow-up to determine guidelines for optimal management and to identify accurate prognostic indicators. The organization of a multicenter approach will guide us towards a better understanding of ILD in children.

Type IV collagen production by rat pulmonary alveolar epithelial cells

Maintenance and repair of the pulmonary alveolar basement membrane are critical processes for preserving normal alveolar structure and function. To elucidate the mechanisms that control type IV collagen production by pulmonary alveolar epithelial cells, type II pneumocytes from rat lungs were isolated and maintained in tissue culture as monolayers. Using Northern blot analysis and metabolic labeling, we found that the cultured epithelial cells express type IV collagen mRNA and incorporate [3H]proline into type IV collagen. To determine the effects of phenotype on control of type IV collagen synthesis, we took advantage of the well-described observation that isolated type II cells lose their distinctive type II features when cultured on plastic in serum-containing medium for 7 days and assume an appearance more like that of type I epithelial cells. We found that [3H]proline incorporation into type IV collagen increased from day 1 to day 2 and thereafter decreased gradually up to day 7. Despite this decrease in [3H]proline incorporation, type IV collagen mRNA increased over the same period. If the loss of type II cell characteristics was prevented by culturing the cells in EHS matrix, a basement membrane-like extracellular matrix, there was little increase in relative abundance of type IV collagen mRNA as compared with cells cultured on plastic. We therefore conclude that type IV collagen production by isolated pulmonary alveolar epithelial cells is controlled, at least in part, by translational or post-translational mechanisms. Furthermore, the full type II cell phenotype is not required for expression of type IV collagen genes.(ABSTRACT TRUNCATED AT 250 WORDS)

Matrix deposition and extracellular processing of newly synthesized collagens in the isolated perfused rat lung

We have examined the matrix deposition and proteolytic processing of newly synthesized interstitial and basement membrane collagens in the isolated perfused adult rat lung. Isolated, perfused, and ventilated lungs were labeled for up to 4 h with radiolabeled proline. Collagens were partially purified from homogenates by salt fractionation and ion exchange chromatography and examined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The major collagenous species were identified as types I, III, and IV collagen by peptide mapping and indirect immunoprecipitation assays. Whereas extraction with neutral salts recovered radiolabeled types I and III collagen, extraction of the neutral salt residue with 2 M guanidine-HCl preferentially recovered types III and IV collagen. Reextraction of the guanidine-HCl residue in the presence of dithiothreitol selectively recovered type IV procollagen (PC) and covalently cross-linked aggregates of type IV chains. In pulse-chase experiments we observed extensive conversion of type I PC to collagen during a 4-h chase. Although type III PC was efficiently converted to p-collagen, only small amounts of fully processed chains were identified. Type IV PC did not undergo detectable proteolytic processing. The isolated perfused rat lung should prove useful for further studies of lung collagen metabolism.